Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3960 results

Sort By:

First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury

Study ID: NCT06922890
Start Date: 2025-07-30
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

9

Intervention / Treatment

Stup -001

Sponsor

Yonsei University

Source: clinicaltrials.gov

Share:
Add to list

Neuropathic Pain Intervention With tDCS in Brazilian Military Personnel (NeuBRAIN Trial)

Study ID: NCT06994390
Start Date: 2026-03-01
End Date: 2030-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

tDCS

sham intervention

Sponsor

Goiás Military Police Hospital

Source: clinicaltrials.gov

Share:
Add to list

Development of a Multipurpose Dashboard to Monitor the Situation of Emergency Departments

Study ID: NCT06372379
Start Date: 2026-01
End Date: 2027-02
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

162000

Intervention / Treatment

no intervention

Sponsor

Mario Negri Institute for Pharmacological Research

Source: clinicaltrials.gov

Share:
Add to list

Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet

Study ID: NCT07007338
Start Date: 2025-09
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Supplementary blood samples and urines samples

Sponsor

Lyon Civilian Hospices

Source: clinicaltrials.gov

Share:
Add to list

Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation

Study ID: NCT06981338
Start Date: 2025-09-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

10

Intervention / Treatment

Allogeneic Wharton's jelly mesenchymal stem cells (WJ-MSCs)

Sponsor

Institut Guttmann

Source: clinicaltrials.gov

Share:
Add to list

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Study ID: NCT07025538
Start Date: 2025-10-09
End Date: 2025-10-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

42

Intervention / Treatment

Best Practice

Biomarker Analysis

Biospecimen Collection

Administration questionnaire

Rheops

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients

Study ID: NCT06352138
Start Date: 2025-07
End Date: 2027-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

280

Intervention / Treatment

Experimental: Epoetin alfa Megalabs® Erythropoietin injectable in intravenous administration.

Active comparator: European Union licenced epoetin alfa

Sponsor

Megalabs

Source: clinicaltrials.gov

Share:
Add to list

Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study

Study ID: NCT06995638
Start Date: 2025-08
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment

Web-based Cognitive Training (with strategy)

Web-based Cognitive Training (without strategy)

Sponsor

Rutgers, The State University of New Jersey

Source: clinicaltrials.gov

Share:
Add to list

Does the 'CATCH My Breath' Vaping Prevention Program Prevent High School Students in Ontario, Canada From Starting to Vape?

Study ID: NCT06825338
Start Date: 2025-10
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

5600

Intervention / Treatment

CATCH My Breath

Sponsor

University of Ontario Institute of Technology

Source: clinicaltrials.gov

Share:
Add to list

Investigating Periprosthetic Fracture Cultures in Arthroplasty

Study ID: NCT06952738
Start Date: 2025-10
End Date: 2027-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Not applicable- observational study

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list